Skip to Main Content
Table 1.

Proportions of MO/MA subpopulations

MO/MA subpopulationPercentage of CD14+ MO/MA*
P value
ND PBEOC PBEOC ascEOC TAMND PB vs EOC PBEOC PB vs EOC ascND PB vs EOC ascND PB vs EOC TAMEOC PB vs EOC TAMEOC asc vs EOC TAM
CD14brightCD16−HLA-DR+ 88%* 57% 33% 62% <0.01 NS <0.01 <0.01 NS NS 
CD14brightCD16−HLA-DR− 3% 36% 31% 6% <0.01 NS <0.01 NS 0.02 0.03 
CD14brightCD16+HLA-DR+ 4% 2% 19% 18% NS 0.04 0.02 <0.01 0.02 NS 
CD14brightCD16+HLA-DR− <1% <1% 11% 1% NS <0.01 <0.01 <0.01 NS NS 
MO/MA subpopulationPercentage of CD14+ MO/MA*
P value
ND PBEOC PBEOC ascEOC TAMND PB vs EOC PBEOC PB vs EOC ascND PB vs EOC ascND PB vs EOC TAMEOC PB vs EOC TAMEOC asc vs EOC TAM
CD14brightCD16−HLA-DR+ 88%* 57% 33% 62% <0.01 NS <0.01 <0.01 NS NS 
CD14brightCD16−HLA-DR− 3% 36% 31% 6% <0.01 NS <0.01 NS 0.02 0.03 
CD14brightCD16+HLA-DR+ 4% 2% 19% 18% NS 0.04 0.02 <0.01 0.02 NS 
CD14brightCD16+HLA-DR− <1% <1% 11% 1% NS <0.01 <0.01 <0.01 NS NS 

Abbreviations: ND, normal donor; PB, peripheral blood; EOC, epithelial ovarian cancer patient; asc, ascites; TAM, tumor-associated macrophage; NS, not significant.

*

Percentages represent proportions of the total number of CD14+ MO/MA.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept